Literature DB >> 9618245

Role of microtubules in the contractile dysfunction of myocytes from tachycardia-induced dilated cardiomyopathy.

M Takahashi1, H Tsutsui, S Kinugawa, K Igarashi-Saito, S Yamamoto, M Yamamoto, H Tagawa, K Imanaka-Yoshida, K Egashira, A Takeshita.   

Abstract

Microtubules of cardiac myocytes are increased in pressure-overloaded cardiac hypertrophy, which interfere with the actin-myosin crossbridge motion and depress muscle contractility. However, it is unknown whether microtubules are increased in non-hypertrophied, dilated cardiomyopathy and, if so, their increase could contribute to the depressed contractility. We assessed the contractile function of isolated left-ventricular (LV) myocytes and also quantitated tubulin mRNA levels as well as free and polymerized tubulin proteins using the LV myocardium obtained from dogs with rapid pacing (240 beats/min, 4 weeks)-induced dilated failing cardiomyopathy (HF; n = 6) and control dogs (n = 6). Myocyte contractility was significantly depressed in HF compared to control. Northern blot analysis indicated that tubulin mRNA levels (normalized to GAPDH mRNA) in HF dogs were upregulated (0.43 +/- 0.04 v 0.13 +/- 0.02; P < 0.01). In contrast, the amount of total tubulins (633 +/- 52 v 697 +/- 42 micrograms/g wet weight; P = N.S.) and the ratio of polymerized tubulin fraction-to-total tubulin (0.44 +/- 0.02 v 0.44 +/- 0.01; P = N.S.) did not differ between the two groups. Immunohistochemical studies showed no apparent differences in the distribution or density of intracellular microtubule network. Further, the exposure of myocytes to colchicine (1 mumol/l, 30 min), which depolymerizes microtubules, did not promote any improvement of the depressed myocyte contraction. Pacing-induced tachycardia increased myocardial tubulin mRNA, but the amount of total and polymerized tubulins were not increased, indicating that alterations in myocyte microtubules do not contribute to the contractile abnormalities in this model of HF.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9618245     DOI: 10.1006/jmcc.1998.0674

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  8 in total

1.  Unloaded shortening velocity in single permeabilized vascular smooth muscle cells is independent of microtubule status.

Authors:  Dahua Zhang; Jennifer Sherwood; Liang Li; Darl R Swartz
Journal:  J Muscle Res Cell Motil       Date:  2004       Impact factor: 2.698

Review 2.  Supporting the heart: Functions of the cardiomyocyte's non-sarcomeric cytoskeleton.

Authors:  Kelly M Grimes; Vikram Prasad; James W McNamara
Journal:  J Mol Cell Cardiol       Date:  2019-04-09       Impact factor: 5.000

Review 3.  The cytoskeleton and related proteins in the human failing heart.

Authors:  S Kostin; S Hein; E Arnon; D Scholz; J Schaper
Journal:  Heart Fail Rev       Date:  2000-10       Impact factor: 4.214

Review 4.  Cardiocyte cytoskeleton in hypertrophied myocardium.

Authors:  G Cooper
Journal:  Heart Fail Rev       Date:  2000-10       Impact factor: 4.214

Review 5.  Tachycardia-mediated cardiomyopathy: recognition and management.

Authors:  Rakesh Gopinathannair; Renee Sullivan; Brian Olshansky
Journal:  Curr Heart Fail Rep       Date:  2009-12

6.  Recovery and recurrence of left ventricular systolic dysfunction in patients with idiopathic dilated cardiomyopathy.

Authors:  Jeonggeun Moon; Young-Guk Ko; Namsik Chung; Jong-Won Ha; Seok-Min Kang; Eui-Young Choi; Se-Joong Rim
Journal:  Can J Cardiol       Date:  2009-05       Impact factor: 5.223

7.  Changes in αB-crystallin, tubulin, and MHC isoforms by hindlimb unloading show different expression patterns in various hindlimb muscles.

Authors:  Hyunseok Jee; Takashi Sakurai; Jae-Young Lim; Hideo Hatta
Journal:  J Exerc Nutrition Biochem       Date:  2014-05-12

8.  Loss of CENP-F Results in Dilated Cardiomyopathy with Severe Disruption of Cardiac Myocyte Architecture.

Authors:  Annabelle Manalo; Alison K Schroer; Aidan M Fenix; Zoe Shancer; John Coogan; Tanner Brolsma; Dylan T Burnette; W David Merryman; David M Bader
Journal:  Sci Rep       Date:  2018-05-15       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.